Search results
Former Merck CEO Ken Frazier on the responsibility of CEOs to uphold principles despite politics
Fortune via Yahoo Finance· 7 months agoOn this week’s episode of Fortune‘s Leadership Next podcast, co-host Alan Murray talks with former...
Shareholders Will Most Likely Find Merck KGaA's (ETR:MRK) CEO Compensation Acceptable
Simply Wall St. via Yahoo Finance· 2 months agoKey Insights Merck KGaA will host its Annual General Meeting on 26th of April CEO Belen Garijo...
Merck allies with Daiichi Sankyo in major bet on antibody cancer drugs
BioPharma Dive via Yahoo Finance· 8 months agoMerck & Co. is making a major investment in the future of its cancer drug business, agreeing to one...
Merck keeps deal focus with Keytruda patent cliff on horizon
BioPharma Dive via Yahoo Finance· 5 months agoMerck & Co. plans to continue seeking out multibillion-dollar biotechnology deals to supplement its...
Ken Frazier, long one of the few Black Fortune 500 CEOs, is fighting against ‘the vestiges of the...
Fortune via Yahoo Finance· 9 months agoKen Frazier, former CEO of pharmaceutical company Merck, had a message for CEOs during Fortune’s CEO...
Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600m
Pharmaceutical Technology via Yahoo Finance· 1 month agoMerck KGaA’s Life Science business in the US and Canada, MilliporeSigma, has entered a definitive...
Merck upgrades guidance on stronger 2023 outlook as COVID business declines
Yahoo Finance· 11 months agoMerck (MRK) reported earnings and upgraded its 2023 guidance Tuesday, as demand slows for COVID...
Germany's Merck KGaA insists chip market remains attractive
Reuters via Yahoo Finance· 2 years agoFRANFURT/LONDON (Reuters) -Merck KGaA does not anticipate that a projected decline in smartphone...
Senate panel grills pharmaceutical company execs over prescription drug prices
USA TODAY via Yahoo News· 4 months agoA Senate committee chaired by Sen. Bernie Sanders grilled the top executives of three major...
Sanders threatens to subpoena J&J, Merck CEOs over drug prices
BioPharma Dive via Yahoo Finance· 5 months agoA Congressional committee may subpoena the CEOs of Johnson & Johnson and Merck & Co. to testify...